1. Fixed drug eruption caused by dimenhydrinate
Sophia Giatrakou, MD, Evangelia Papadavid, MD, PhD, Dimitrios Kalogeromitros, MD, PhD, Konstandinos Theodoropoulos, MD, Eugenia Toumbis-Ioannou, MD, PhD, Michalis Makris, MD, PhD, Nikolaos G. Stavrianeas, MD, PhD 
Journal of the American Academy of Dermatology 
Volume 64, Issue 3, Pages (March 2011)
DOI: /j.jaad
Copyright © 2009 American Academy of Dermatology, Inc. Terms and Conditions

2. Fig 1
Skin lesions of patient after oral provocation test. Diagnosis of fixed drug eruption from dimenhydrinate was confirmed.
Journal of the American Academy of Dermatology  , DOI: ( /j.jaad )
Copyright © 2009 American Academy of Dermatology, Inc. Terms and Conditions

3. Fig 2
Lesion resolved in approximately 20 days with application of topical steroid cream, and had not recurred at time of our writing.
Journal of the American Academy of Dermatology  , DOI: ( /j.jaad )
Copyright © 2009 American Academy of Dermatology, Inc. Terms and Conditions

4. Fig 3
CD8– T cells in skin lesions became reactivated after re-exposure to causative drug, documented with immunostaining using anti-CD8. (Hematoxylin counter stain; original magnification: ×40.)
Journal of the American Academy of Dermatology  , DOI: ( /j.jaad )
Copyright © 2009 American Academy of Dermatology, Inc. Terms and Conditions